Biotech in New Zealand
New Zealand has one of the fastest growing biotechnology industries in the world. What does this mean for our economy, employment, and research?
The biotech boom
Biotechnology is booming in New Zealand. Funding for biotechnology research and development increased by 20% between 2004 and 2005. In total, NZ$640 million was invested in biotechnology research in 2005.
Biotech affects our economy
Biotechnology for a better future, Part 4
New Zealand biotechnology is a developing, world-class industry. Find out more about the exciting work being done, and how they are regulated, in this last of a 4-part series produced by NZBio.
See below for links to the other videos in this series.
This clip was produced in conjunction with NZBio.
Biotechnology for a better future, Part 4
New Zealand biotechnology is a developing, world-class industry. Find out more about the exciting work being done, and how they are regulated, in this last of a 4-part series produced by NZBio.
See below for links to the other videos in this series.
This clip was produced in conjunction with NZBio.
See the other videos in the series, which look at how biotechnology has the potential to create better healthcare, improved foods, better and safer agriculture and cleaner industrial processing.
Research and development in the area of biotechnology has increased employment opportunities and the number of new companies being formed in New Zealand, enabling more efficient and competitive industries. Many would argue that it has also improved our quality of life. In financial terms, biotechnology earns New Zealand $300–400 million each year.
Who’s doing biotech in New Zealand?
In 2005, there were 126 organisations involved in biotechnology research in New Zealand. These organisations include universities, Crown Research Institutes (CRIs), Centres of Research Excellence (CoREs) and privately owned companies. These privately owned companies are one of the fastest growing sectors in biotechnology, with the number almost doubling between 2004 and 2006.
Biotech companies that listed on the New Zealand stock exchange in 2005 were estimated to be worth about NZ$2.1 billion – New Zealand biotechnology is big business!
New biotechnology companies are sometimes spin-outs, which arise from research being carried out by universities, CRIs or other companies. Spin-out companies tend to focus on a new idea or commercialise intellectual property (IP). Examples of spin-out companies are:
Biopolymer Network – a spin-out from Canesis, Crop & Food Research and Scion
Zygem – a spin-out from the University of Auckland and the University of Waikato
Keratec – a spin-out from Canesis.
Find out more about research and development in New Zealand.
What are New Zealand’s biotechnology strengths?
New Zealand's strengths in biotechnology
Why does New Zealand have such a good reputation for producing world-leading science? Representatives from the biotechnology sector provide some answers.
This clip was produced in conjunction with NZBio.
New Zealand's strengths in biotechnology
Why does New Zealand have such a good reputation for producing world-leading science? Representatives from the biotechnology sector provide some answers.
This clip was produced in conjunction with NZBio.
More than 2,200 people work in biotechnology in New Zealand. They specialise in four main research areas:
Agricultural biotechnology (35%)
Medical devices and diagnostics (28%)
Human health applications (23%)
Industrial applications (14%)
Who uses New Zealand’s biotechnology?
New Zealand exports its biotechnology to over 60 countries. The income from these exports was NZ$142 million in 2005.
